Keros Therapeutics, Inc.
(KROS - NASDAQ)
11,01 USD
📋 Profilo Aziendale

Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need.

|